Loading…
MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism
Resistance to chemotherapeutic agents is one of the distinct features of cancer cells. We evaluate the role of activated MEK-ERK signaling in Camptotecin/irinotecan (CPT-11)-induced cell death using constitutively activated MEK1-transfected normal rat intestinal epithelial cells (IEC-caMEK cells). A...
Saved in:
Published in: | Digestive diseases and sciences 2007-10, Vol.52 (10), p.2757-2765 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733 |
container_end_page | 2765 |
container_issue | 10 |
container_start_page | 2757 |
container_title | Digestive diseases and sciences |
container_volume | 52 |
creator | HORIKAWA, Youhei OTAKA, Michiro DUBOIS, Raymond N WATANABE, Sumio KOMATSU, Koga JIN, Mario ODASHIMA, Masaru WADA, Isao MATSUHASHI, Tamotsu OHBA, Reina OYAKE, Jinko HATAKEYAMA, Natsumi |
description | Resistance to chemotherapeutic agents is one of the distinct features of cancer cells. We evaluate the role of activated MEK-ERK signaling in Camptotecin/irinotecan (CPT-11)-induced cell death using constitutively activated MEK1-transfected normal rat intestinal epithelial cells (IEC-caMEK cells). A CPT-11-induced inhibitory concentration of 50% was determined by WST assay. Apoptosis was evaluated by DNA staining and fragmented DNA analysis. Protein expressions were analyzed by western blotting. We also examined the role of cyclooxygenase-2 in the cell systems. IEC-caMEK cells possessed survival advantages compared to control cells. Apoptosis was remarkably suppressed in IEC-caMEK cells. Western blot analysis revealed increased expression of Bcl-2, Bcl-xL, Mcl-1, and COX-2 and decreased expression of Bak in IEC-caMEK cells. The COX-2 selective inhibitor ameliorated the antiapoptotic nature of IEC-caMEK cells. MEK activation suppressed CPT-11-induced apoptosis in IEC-caMEK cells via a COX-2- dependent mechanism. Therefore, MEK-ERK signaling may contribute to the drug-resistant nature of cancer cells. |
doi_str_mv | 10.1007/s10620-007-9798-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68240087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1332022861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733</originalsourceid><addsrcrecordid>eNpdkU-LFDEQxYMo7rj6AbxIEPQWrSTT6fRRhvUPrqyHFbw1maTaydKdblPpRb-9GWZgwUvVO_yq6hWPsZcS3kmA9j1JMApElaJrOyvgEdvIptVCNcY-ZhuQpmopzQV7RnQHAF0rzVN2IVvdaS3thv35dvWVO1_ivStxTpzWZclIhMR332-lFDGF1WPgbpmXMlMkHhPPrtRWkEpMbuS4xHLAMVbpcRyJl0Oe118H7vju5qdQIuCCKWAqfEJ_cCnS9Jw9GdxI-OLcL9mPj1e3u8_i-ubTl92Ha-F1Y4rwdnCggtm2ATVo8HsjlVZya02AzgPUut9ja7ptaGznoBmktQ4HDEHXN_Ule3vau-T591od91Oko0uXcF6pN1ZtAWxbwdf_gXfzmut71NdzqrqRTYXkCfJ5Jso49EuOk8t_ewn9MZP-lEl_lMdMeqgzr86L1_2E4WHiHEIF3pwBR96NQ3bJR3rgOqlaq0D_AweklAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214235615</pqid></control><display><type>article</type><title>MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism</title><source>Springer Nature</source><creator>HORIKAWA, Youhei ; OTAKA, Michiro ; DUBOIS, Raymond N ; WATANABE, Sumio ; KOMATSU, Koga ; JIN, Mario ; ODASHIMA, Masaru ; WADA, Isao ; MATSUHASHI, Tamotsu ; OHBA, Reina ; OYAKE, Jinko ; HATAKEYAMA, Natsumi</creator><creatorcontrib>HORIKAWA, Youhei ; OTAKA, Michiro ; DUBOIS, Raymond N ; WATANABE, Sumio ; KOMATSU, Koga ; JIN, Mario ; ODASHIMA, Masaru ; WADA, Isao ; MATSUHASHI, Tamotsu ; OHBA, Reina ; OYAKE, Jinko ; HATAKEYAMA, Natsumi</creatorcontrib><description>Resistance to chemotherapeutic agents is one of the distinct features of cancer cells. We evaluate the role of activated MEK-ERK signaling in Camptotecin/irinotecan (CPT-11)-induced cell death using constitutively activated MEK1-transfected normal rat intestinal epithelial cells (IEC-caMEK cells). A CPT-11-induced inhibitory concentration of 50% was determined by WST assay. Apoptosis was evaluated by DNA staining and fragmented DNA analysis. Protein expressions were analyzed by western blotting. We also examined the role of cyclooxygenase-2 in the cell systems. IEC-caMEK cells possessed survival advantages compared to control cells. Apoptosis was remarkably suppressed in IEC-caMEK cells. Western blot analysis revealed increased expression of Bcl-2, Bcl-xL, Mcl-1, and COX-2 and decreased expression of Bak in IEC-caMEK cells. The COX-2 selective inhibitor ameliorated the antiapoptotic nature of IEC-caMEK cells. MEK activation suppressed CPT-11-induced apoptosis in IEC-caMEK cells via a COX-2- dependent mechanism. Therefore, MEK-ERK signaling may contribute to the drug-resistant nature of cancer cells.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-007-9798-0</identifier><identifier>PMID: 17393318</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Animals ; Apoptosis - drug effects ; Biological and medical sciences ; Blotting, Western ; Bones, joints and connective tissue. Antiinflammatory agents ; Camptothecin - analogs & derivatives ; Camptothecin - pharmacology ; Cell Survival ; Cyclooxygenase 2 - drug effects ; Cyclooxygenase 2 - metabolism ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Epithelial Cells - drug effects ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Intestinal Mucosa - drug effects ; Intestinal Mucosa - metabolism ; Intestinal Mucosa - pathology ; Intestinal Neoplasms - metabolism ; Intestinal Neoplasms - pathology ; Medical sciences ; Mitogen-Activated Protein Kinase Kinases - drug effects ; Mitogen-Activated Protein Kinase Kinases - metabolism ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - pathology ; Pharmacology. Drug treatments ; Rats ; Signal Transduction ; Tumor Cells, Cultured</subject><ispartof>Digestive diseases and sciences, 2007-10, Vol.52 (10), p.2757-2765</ispartof><rights>2007 INIST-CNRS</rights><rights>Springer Science+Business Media, LLC 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733</citedby><cites>FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19127820$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17393318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HORIKAWA, Youhei</creatorcontrib><creatorcontrib>OTAKA, Michiro</creatorcontrib><creatorcontrib>DUBOIS, Raymond N</creatorcontrib><creatorcontrib>WATANABE, Sumio</creatorcontrib><creatorcontrib>KOMATSU, Koga</creatorcontrib><creatorcontrib>JIN, Mario</creatorcontrib><creatorcontrib>ODASHIMA, Masaru</creatorcontrib><creatorcontrib>WADA, Isao</creatorcontrib><creatorcontrib>MATSUHASHI, Tamotsu</creatorcontrib><creatorcontrib>OHBA, Reina</creatorcontrib><creatorcontrib>OYAKE, Jinko</creatorcontrib><creatorcontrib>HATAKEYAMA, Natsumi</creatorcontrib><title>MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>Resistance to chemotherapeutic agents is one of the distinct features of cancer cells. We evaluate the role of activated MEK-ERK signaling in Camptotecin/irinotecan (CPT-11)-induced cell death using constitutively activated MEK1-transfected normal rat intestinal epithelial cells (IEC-caMEK cells). A CPT-11-induced inhibitory concentration of 50% was determined by WST assay. Apoptosis was evaluated by DNA staining and fragmented DNA analysis. Protein expressions were analyzed by western blotting. We also examined the role of cyclooxygenase-2 in the cell systems. IEC-caMEK cells possessed survival advantages compared to control cells. Apoptosis was remarkably suppressed in IEC-caMEK cells. Western blot analysis revealed increased expression of Bcl-2, Bcl-xL, Mcl-1, and COX-2 and decreased expression of Bak in IEC-caMEK cells. The COX-2 selective inhibitor ameliorated the antiapoptotic nature of IEC-caMEK cells. MEK activation suppressed CPT-11-induced apoptosis in IEC-caMEK cells via a COX-2- dependent mechanism. Therefore, MEK-ERK signaling may contribute to the drug-resistant nature of cancer cells.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Camptothecin - analogs & derivatives</subject><subject>Camptothecin - pharmacology</subject><subject>Cell Survival</subject><subject>Cyclooxygenase 2 - drug effects</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Intestinal Mucosa - drug effects</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Intestinal Mucosa - pathology</subject><subject>Intestinal Neoplasms - metabolism</subject><subject>Intestinal Neoplasms - pathology</subject><subject>Medical sciences</subject><subject>Mitogen-Activated Protein Kinase Kinases - drug effects</subject><subject>Mitogen-Activated Protein Kinase Kinases - metabolism</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Signal Transduction</subject><subject>Tumor Cells, Cultured</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpdkU-LFDEQxYMo7rj6AbxIEPQWrSTT6fRRhvUPrqyHFbw1maTaydKdblPpRb-9GWZgwUvVO_yq6hWPsZcS3kmA9j1JMApElaJrOyvgEdvIptVCNcY-ZhuQpmopzQV7RnQHAF0rzVN2IVvdaS3thv35dvWVO1_ivStxTpzWZclIhMR332-lFDGF1WPgbpmXMlMkHhPPrtRWkEpMbuS4xHLAMVbpcRyJl0Oe118H7vju5qdQIuCCKWAqfEJ_cCnS9Jw9GdxI-OLcL9mPj1e3u8_i-ubTl92Ha-F1Y4rwdnCggtm2ATVo8HsjlVZya02AzgPUut9ja7ptaGznoBmktQ4HDEHXN_Ule3vau-T591od91Oko0uXcF6pN1ZtAWxbwdf_gXfzmut71NdzqrqRTYXkCfJ5Jso49EuOk8t_ewn9MZP-lEl_lMdMeqgzr86L1_2E4WHiHEIF3pwBR96NQ3bJR3rgOqlaq0D_AweklAI</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>HORIKAWA, Youhei</creator><creator>OTAKA, Michiro</creator><creator>DUBOIS, Raymond N</creator><creator>WATANABE, Sumio</creator><creator>KOMATSU, Koga</creator><creator>JIN, Mario</creator><creator>ODASHIMA, Masaru</creator><creator>WADA, Isao</creator><creator>MATSUHASHI, Tamotsu</creator><creator>OHBA, Reina</creator><creator>OYAKE, Jinko</creator><creator>HATAKEYAMA, Natsumi</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20071001</creationdate><title>MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism</title><author>HORIKAWA, Youhei ; OTAKA, Michiro ; DUBOIS, Raymond N ; WATANABE, Sumio ; KOMATSU, Koga ; JIN, Mario ; ODASHIMA, Masaru ; WADA, Isao ; MATSUHASHI, Tamotsu ; OHBA, Reina ; OYAKE, Jinko ; HATAKEYAMA, Natsumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Camptothecin - analogs & derivatives</topic><topic>Camptothecin - pharmacology</topic><topic>Cell Survival</topic><topic>Cyclooxygenase 2 - drug effects</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Intestinal Mucosa - drug effects</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Intestinal Mucosa - pathology</topic><topic>Intestinal Neoplasms - metabolism</topic><topic>Intestinal Neoplasms - pathology</topic><topic>Medical sciences</topic><topic>Mitogen-Activated Protein Kinase Kinases - drug effects</topic><topic>Mitogen-Activated Protein Kinase Kinases - metabolism</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Signal Transduction</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HORIKAWA, Youhei</creatorcontrib><creatorcontrib>OTAKA, Michiro</creatorcontrib><creatorcontrib>DUBOIS, Raymond N</creatorcontrib><creatorcontrib>WATANABE, Sumio</creatorcontrib><creatorcontrib>KOMATSU, Koga</creatorcontrib><creatorcontrib>JIN, Mario</creatorcontrib><creatorcontrib>ODASHIMA, Masaru</creatorcontrib><creatorcontrib>WADA, Isao</creatorcontrib><creatorcontrib>MATSUHASHI, Tamotsu</creatorcontrib><creatorcontrib>OHBA, Reina</creatorcontrib><creatorcontrib>OYAKE, Jinko</creatorcontrib><creatorcontrib>HATAKEYAMA, Natsumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HORIKAWA, Youhei</au><au>OTAKA, Michiro</au><au>DUBOIS, Raymond N</au><au>WATANABE, Sumio</au><au>KOMATSU, Koga</au><au>JIN, Mario</au><au>ODASHIMA, Masaru</au><au>WADA, Isao</au><au>MATSUHASHI, Tamotsu</au><au>OHBA, Reina</au><au>OYAKE, Jinko</au><au>HATAKEYAMA, Natsumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>52</volume><issue>10</issue><spage>2757</spage><epage>2765</epage><pages>2757-2765</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Resistance to chemotherapeutic agents is one of the distinct features of cancer cells. We evaluate the role of activated MEK-ERK signaling in Camptotecin/irinotecan (CPT-11)-induced cell death using constitutively activated MEK1-transfected normal rat intestinal epithelial cells (IEC-caMEK cells). A CPT-11-induced inhibitory concentration of 50% was determined by WST assay. Apoptosis was evaluated by DNA staining and fragmented DNA analysis. Protein expressions were analyzed by western blotting. We also examined the role of cyclooxygenase-2 in the cell systems. IEC-caMEK cells possessed survival advantages compared to control cells. Apoptosis was remarkably suppressed in IEC-caMEK cells. Western blot analysis revealed increased expression of Bcl-2, Bcl-xL, Mcl-1, and COX-2 and decreased expression of Bak in IEC-caMEK cells. The COX-2 selective inhibitor ameliorated the antiapoptotic nature of IEC-caMEK cells. MEK activation suppressed CPT-11-induced apoptosis in IEC-caMEK cells via a COX-2- dependent mechanism. Therefore, MEK-ERK signaling may contribute to the drug-resistant nature of cancer cells.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>17393318</pmid><doi>10.1007/s10620-007-9798-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2007-10, Vol.52 (10), p.2757-2765 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_miscellaneous_68240087 |
source | Springer Nature |
subjects | Animals Apoptosis - drug effects Biological and medical sciences Blotting, Western Bones, joints and connective tissue. Antiinflammatory agents Camptothecin - analogs & derivatives Camptothecin - pharmacology Cell Survival Cyclooxygenase 2 - drug effects Cyclooxygenase 2 - metabolism Enzyme Activation - drug effects Enzyme Inhibitors - pharmacology Epithelial Cells - drug effects Epithelial Cells - metabolism Epithelial Cells - pathology Intestinal Mucosa - drug effects Intestinal Mucosa - metabolism Intestinal Mucosa - pathology Intestinal Neoplasms - metabolism Intestinal Neoplasms - pathology Medical sciences Mitogen-Activated Protein Kinase Kinases - drug effects Mitogen-Activated Protein Kinase Kinases - metabolism Neoplasms, Experimental - drug therapy Neoplasms, Experimental - metabolism Neoplasms, Experimental - pathology Pharmacology. Drug treatments Rats Signal Transduction Tumor Cells, Cultured |
title | MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MEK%20activation%20suppresses%20CPT11-induced%20apoptosis%20in%20rat%20intestinal%20epithelial%20cells%20through%20a%20COX-2-dependent%20mechanism&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=HORIKAWA,%20Youhei&rft.date=2007-10-01&rft.volume=52&rft.issue=10&rft.spage=2757&rft.epage=2765&rft.pages=2757-2765&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/s10620-007-9798-0&rft_dat=%3Cproquest_cross%3E1332022861%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-c8fa02d647de3030cb612321486d09c00d09bbe7694d589a05f188aefedd31733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=214235615&rft_id=info:pmid/17393318&rfr_iscdi=true |